[ Price : $8.95]
Johnson & Johnson reports new icotrokinra (JNJ-2113) data from a Phase 3 studys subgroup analysis in moderate-to-severe plaque pso...[ Price : $8.95]
Two Hyman, Phelps & McNamara attorneys say reductions in staff at FDA are resulting in significant delays in agency responses to F...[ Price : $8.95]
The Associated Press says FDA has reversed course and will permit some product reviewers and supervisors to work from home at leas...[ Price : $8.95]
Alzheon says its Phase 3 valiltramiprosate trial in early Alzheimers disease patients did not meet its primary endpoint of slowing...[ Price : $8.95]
FDA clears the Dexcom G7 15 Day continuous glucose monitoring system.[ Price : $8.95]
FDA clears an Intuitive 510(k) for the SP SureForm 45 stapler for use with its da Vinci SP surgical system in thoracic, colorectal...[ Price : $8.95]
FDA accepts for review an Outlook Therapeutics BLA resubmission for ONS-5010 (bevacizumab-vikg), an investigational ophthalmic for...